Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.81% |
| Dec 31, 2025 | 8.18% |
| Sep 30, 2025 | 305.18% |
| Sep 30, 2023 | -20.78% |
| Jun 30, 2023 | -16.38% |
| Mar 31, 2023 | -17.18% |
| Dec 31, 2022 | -15.87% |
| Sep 30, 2022 | -13.47% |
| Jun 30, 2022 | -4.88% |
| Mar 31, 2022 | -5.09% |
| Dec 31, 2021 | -13.83% |
| Sep 30, 2021 | -12.84% |
| Jun 30, 2021 | -11.27% |
| Mar 31, 2021 | -10.83% |
| Dec 31, 2020 | -6.18% |
| Sep 30, 2020 | -6.58% |
| Jun 30, 2020 | -7.17% |
| Mar 31, 2020 | -7.30% |
| Dec 31, 2019 | -6.32% |
| Sep 30, 2019 | -5.54% |
| Jun 30, 2019 | -3.36% |
| Mar 31, 2019 | 0.52% |
| Dec 31, 2018 | -1.17% |
| Sep 30, 2018 | -4.15% |
| Jun 30, 2018 | -4.20% |
| Mar 31, 2018 | -4.71% |
| Dec 31, 2017 | -1.36% |
| Sep 30, 2017 | -3.22% |
| Jun 30, 2017 | 7.92% |
| Mar 31, 2017 | 1.72% |
| Dec 31, 2016 | 56.13% |
| Sep 30, 2016 | 38.65% |
| Jun 30, 2016 | -0.70% |
| Mar 31, 2016 | -5.75% |
| Dec 31, 2015 | -8.08% |
| Sep 30, 2015 | -2.06% |
| Jun 30, 2015 | 37.78% |
| Mar 31, 2015 | -7.05% |
| Dec 31, 2014 | -6.14% |
| Sep 30, 2014 | 14.55% |
| Jun 30, 2014 | 10.96% |
| Mar 31, 2014 | -5.18% |